Skip to main content

GoodRx Holdings, Inc.

corporate_fare Company Profile

GoodRx Holdings, Inc.

GDRX·NASDAQ·Healthcare·CIK 0001809519

GoodRx is a consumer-focused digital healthcare platform in the United States, aiming to help Americans save time and money on medications. The company began with a price comparison tool for prescriptions, providing free access to lower medication prices. This platform processes over 420 billion pricing data points daily, integrating this data into a user-friendly interface that offers dynamic, geographically relevant prescription pricing. It also provides access to negotiated prices through GoodRx codes, usable for prescription savings across the United States. GoodRx's expanded platform now offers price transparency and affordability solutions for generic and brand medications to both consumers and healthcare providers. Its services include other healthcare products and services, such as certain condition-specific end-to-end solutions, telehealth services, and wellness-related content. The company's offerings aim to provide significant savings to consumers and promote greater medication awareness, access, and adherence, faster treatment, and improved patient outcomes. GoodRx serves consumers, healthcare providers, pharmacies, and pharmaceutical manufacturers across the United States.

GoodRx Holdings, Inc. (NASDAQ:GDRX) is a publicly traded company in the Healthcare sector. Wiseek monitors GDRX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • GoodRx Projects 2026 Revenue Between $765M and $785M
  • GoodRx Reports Steep 89% Net Income Drop Amid Core Prescription Business Decline and Unresolved $30.5M Legal Liability
  • GoodRx Reports Q1 Revenue Decline and 89% Net Income Drop, but Raises Full-Year Guidance
  • GoodRx Expands Offerings with Ozempic Pill, Available for as Low as $149/Month
  • GoodRx Discloses $3M Executive Retention Bonuses Despite Missed Targets, Details 2026 Equity Grants, and Recent Board Departures

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$796.85M
Net Income
$30.44M
Diluted EPS
$0.09
Op. Cash Flow
$167.9M
Free Cash Flow
$164.38M
Operating Income
$87.49M
Cash & Equivalents
$261.82M
Total Debt
$488.26M
Debt / Equity
0.79×
Net Margin
3.8%
Shares Outstanding
356.33M sh
Source: 10-K · filed 2026-02-25 · accession 0001809519-26-000031
Browse all tickers starting with G →
$2.65
52-week range · as of 2026-05-06 $1.77 – $5.81
Market cap
$897.49M
Volume
673.7K (0.4× avg)
3-mo avg 1.8M
Live data · 2026-06-14 05:13 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GDRX - Latest Insights

GDRX
May 06, 2026, 4:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.57
Real-time Price: $2.65 info
Change: +$0.0806 (+3%) info
Market Cap: $897.49M info
GDRX
May 06, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.54
Real-time Price: $2.65 info
Change: +$0.110 (+4%) info
Market Cap: $897.49M info
GDRX
May 06, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.54
Real-time Price: $2.65 info
Change: +$0.110 (+4%) info
Market Cap: $897.49M info
GDRX
May 01, 2026, 9:23 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.39
Real-time Price: $2.65 info
Change: +$0.260 (+11%) info
Market Cap: $897.49M info
GDRX
Apr 29, 2026, 4:14 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $2.65 info
Change: +$0.350 (+15%) info
Market Cap: $897.49M info
GDRX
Mar 06, 2026, 9:01 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $2.26
Real-time Price: $2.65 info
Change: +$0.390 (+17%) info
Market Cap: $897.49M info
GDRX
Feb 25, 2026, 6:27 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $2.12
Real-time Price: $2.65 info
Change: +$0.535 (+25%) info
Market Cap: $897.49M info
GDRX
Feb 25, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.19
Real-time Price: $2.65 info
Change: +$0.460 (+21%) info
Market Cap: $897.49M info